STOML2 and liver cancer: For external validation, we utilized liver cancer GWAS outcome data from a different cohort (ieu-b-4953) to validate the three MR proteins ASS1, KRT8, and STOML2, which presented the highest posterior probability in the colocalization analysis (Fig. 3E).